Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you live in Surrey and want to know how to access Wegovy (semaglutide 2.4mg), the short answer is this: it is a prescription-only medicine, which means a qualified prescriber must assess your suitability before it can be dispensed — regardless of where in the county you are. There is no GP referral or in-person appointment required through a regulated online pharmacy, and the process can move quickly. Wegovy is licensed in the UK for adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition, and it works by acting on GLP-1 receptors in the brain to reduce appetite and slow how fast the stomach empties. Clinical trials published in the New England Journal of Medicine found an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose. Because it is a prescription medicine, a prescriber decides whether it is right for you — not a website form processed automatically.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before anything else, it helps to know what a prescriber is actually looking at. Wegovy is licensed for adults with a BMI at or above 30, or at or above 27 where a weight-related condition is present, things like high blood pressure, raised cholesterol, type 2 diabetes or obstructive sleep apnoea. BMI alone does not settle the question. A prescriber will also consider your medical history, current medicines and any contraindications: Wegovy is not recommended during pregnancy or breastfeeding, is not licensed for under-18s, and requires careful thought if you have a history of pancreatitis or certain gastrointestinal conditions.
The NHS semaglutide medicines page sets out the main contraindications and side-effect profile in plain language, and it is worth reading before you start a consultation. Lower BMI thresholds of 2.5 kg/m² apply for some ethnic backgrounds under UK guidance, so the 30 and 27 figures are starting points rather than firm cut-offs for everyone. If you are unsure whether you qualify, our clinical team can assess your full picture. You can read more about what influences eligibility on our Wegovy overview page.
For Surrey residents who do not want to wait for an NHS referral (and NHS waiting lists for specialist weight management services can be long) a regulated online pharmacy offers a private route. At nume, the process begins with a free consultation that a GPhC-registered Independent Prescriber reads and assesses personally, the same day it is submitted. A real clinician reviews your answers; your case does not go to an automated triage tool.
Part of that process includes photo-ID verification and live weight confirmation, which sits alongside a check of any evidence needed for transfer patients or dose increases. If you are already taking semaglutide through another provider and want to transfer, your prescriber will want to see evidence of your current dose and recent weight. For new patients, the consultation covers your health history, your goals and any medicines you are already taking. Detail about how our prescribers approach this is on the clinical team page.
Once approved, orders placed before 12pm on a working day are dispatched the same day by DPD, arriving the next working day in plain, unbranded packaging. For many people in Surrey that means the pen is in their fridge before the following morning's school run.
The first pen is not the therapeutic dose. Wegovy starts at 0.25mg weekly, a tolerability stage designed to let your body adjust before the dose climbs. Titration typically steps up every four weeks through 0.5mg, 1.0mg and 1.7mg before reaching the 2.4mg maintenance dose. In April 2026 the MHRA approved a dedicated 7.2mg single-dose pen as a higher maintenance option for eligible adults with a BMI of 30 or above; whether that dose is appropriate for a given patient is a clinical decision made at review.
Side effects are most noticeable in the early weeks and after each step up. Nausea is the one patients mention most. Eating smaller portions, avoiding rich or fatty foods and staying well hydrated all help. Urgent medical attention is needed for severe, persistent abdominal pain that spreads to the back, a potential sign of pancreatitis, which the MHRA flagged in a Drug Safety Update in January 2026. You can read more about what individual doses involve on the 0.25mg and 0.5mg starter information page or the step-two dosing page. Any concerns about your eyes during treatment should be reviewed promptly; our page on vision changes and Wegovy covers what the evidence says.
Private Wegovy treatment is not cheap. Since Eli Lilly's UK price adjustment in September 2025 (for tirzepatide) triggered broader market repricing, typical monthly costs across providers range roughly £149–£375 depending on dose and service. A full breakdown of what private treatment costs and what those prices should include is on our Wegovy cost page.
One thing worth saying plainly: the lower the price looks, the more carefully you should check the seller. The MHRA has seized counterfeit weight-loss pens sold through social media and unverified websites, including fake pens found to contain insulin. Any legitimate supplier of Wegovy in the UK must be registered with the GPhC. You can verify any online pharmacy using the GPhC pharmacy register before handing over payment or personal information. Sellers offering these medicines without a valid prescription should be reported via the MHRA's Yellow Card scheme. Our grey-market semaglutide page covers the risks in more detail if you have seen unusually low prices advertised locally.
If you are ready to explore whether Wegovy is right for you, speak to our prescribers through a free consultation, there is no obligation, and the clinical review happens the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.